ARS Pharmaceuticals, Inc. Depreciation in USD from Q1 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ARS Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to 2024.
  • ARS Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $11K, a 45% decline year-over-year.
  • ARS Pharmaceuticals, Inc. annual Depreciation for 2024 was $79K, a 8.22% increase from 2023.
  • ARS Pharmaceuticals, Inc. annual Depreciation for 2023 was $73K, a 115% increase from 2022.
  • ARS Pharmaceuticals, Inc. annual Depreciation for 2022 was $34K, a 95.7% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

ARS Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11K -$9K -45% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $20K -$30K -60% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $50K -$136K -73.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $186K +$47K +33.8% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-13
Q1 2020 $139K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13

ARS Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $79K +$6K +8.22% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $73K +$39K +115% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $34K -$749K -95.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $783K +$146K +22.9% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 $637K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.